On the contrary, FAK acts as a key mediator in cell-ECM interactions that contributed to tumorigenesis and progression by stimulating AGO2 to activate the FAK/PI3K/Akt signaling pathway in head and neck squamous cell carcinomas [29]. Here, AGO2 is linked to head and neck squamous cell carcinoma.